Cargando…
Glutamine Synthetase Drugability beyond Its Active Site: Exploring Oligomerization Interfaces and Pockets
Background: Glutamine synthetase (GS) is a crucial enzyme to the nitrogen cycle with great commercial and pharmaceutical value. Current inhibitors target the active site, affecting GS activity indiscriminately in all organisms. As the active site is located at the interface between two monomers, the...
Autores principales: | Moreira, Cátia, Ramos, Maria J., Fernandes, Pedro A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6274088/ https://www.ncbi.nlm.nih.gov/pubmed/27509490 http://dx.doi.org/10.3390/molecules21081028 |
Ejemplares similares
-
Emerging Role of Tyrosine Kinases as Drugable Targets in Cancer
por: Na, Il-Kang, et al.
Publicado: (2015) -
Chemical Proteomic Analysis
Reveals the Drugability
of the Kinome of Trypanosoma brucei
por: Urbaniak, Michael D., et al.
Publicado: (2012) -
Reaching Un-Drugable Intracellular Targets with the Long Arm of Antibodies
por: Scheinberg, David A., et al.
Publicado: (2013) -
Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancer
por: Amatu, Alessio, et al.
Publicado: (2015) -
The glutamine synthetase gene family in Populus
por: Castro-Rodríguez, Vanessa, et al.
Publicado: (2011)